Sotera Health Reports Strong Growth, EBITDA Expansion Amid Capital Allocation Plans

Sotera Health (SHC) highlighted its sustained growth trajectory and operational efficiency during its appearance at the Wells Fargo 21st Annual Healthcare Conference, emphasizing revenue expansion and margin improvements. The company reported a 12-month revenue of $1.22 billion, marking an 8.15% increase and the 20th consecutive year of annual growth. EBITDA reached $577 million, with margins consistently above 50%, reflecting operational discipline and cost control. Management also outlined an 118-basis-point expansion in EBITDA margins in 2025, with projections for a 20- to 25-basis-point further improvement in 2026, aligning with its long-term outlook for 50 to 150 basis points by 2027.